Laminar Pharma

We are a pioneering biopharmaceutical company, focused on the discovery, rational design and initial clinical development of drugs. Our goal is for melitherapy drugs to become reference treatments worldwide for serious diseases with unmet medical needs, such as glioblastoma and other aggressive cancers, as well as neurodegenerative, metabolic and inflammatory diseases. We are proud to bring an entrepreneurial spirit to the Innovation and Technology Park (ParcBIT) in our home island of Mallorca, Spain, where the main economic activity is tourism. Still, we are convinced that bringing together passionate and talented people, valuing their work as individuals and teams and giving them freedom to pursue clear, shared goals, breeds success. We carry out translational research with the goal of delivering treatments for serious illnesses which lack effective therapies. Through this mutually beneficial mentoring scheme, we aim to provide opportunities for young scientists to develop their career in the industrial sector. We believe that companies must be useful to the public, so we apply ourselves to improve the quality of life of all citizens. Members approve the strategic and business plans, as well as the management goals and annual budgets.